Ameloblastic FIBROMA is a rare mixed odontogenic tumor [1, 2]. The average age of affliction is 15 years old [3]. Tumor growth is slow and painless and leads to an expansion of jaws and migration and displacement of teeth and it is often asymptomatic [2, 3]. Several cases of malignant transformation to Ameloblastic fibrosarcoma (AFS) have been reported [4]. The patient was a 5-year old boy complaining of toothache in left part and acute swelling. In the radiological examination (Fig. A-1), soap bubble multilocular radiolucent lesion was found in the area between D, E, and 6 teeth of the left side of mandible. Radiolucency limit was specified and a thin sclerotic margin was found around the lesion. The lesion had caused posterior displacement of the tooth bud 6. The tooth bud 5 was missing and no change was found in the lamina dura of any of the teeth of the involved area. Considering the child’s age, the most probable clinical diagnoses were dentigyrus cyst and ameloblastic FIBROMA. In histopathology, the second case was proved (Fig. 2). The mass was completely enucleated and in the next six month follow-up, no symptom of recurrence was found (Fig. B-1).

Giant cell FIBROMA is a fibrous tumor which represents about 2 to 5% of all oral fibrotic proliferations. Compared to traumatic FIBROMA, giant (traumatic FIBROMA or irritation FIBROMA) cell FIBROMA occurs at a younger age. In about 60% of the cases the lesion is diagnosed within the first three decades of life and is slightly more in women. 50% of the cases is observed in the gum and will appear as a nodule with a papillary surface [1]. The giant cell FIBROMA is treated by conservative excisional surgery and recurrence of the lesion is rare [2].The importance of the reported case is a smooth-surfaced giant cell FIBROMA associated with a 58-year old man with chronic irritation in the lower lip (Fig.1).

Primary cardiac tumors are quite rare, especially in the pediatric age group, and their atypical presentations often prevent a timely diagnosis. Most primary cardiac tumors in the pediatric age group are benign. FIBROMAs are generally reported as the second most common primary cardiac tumors in the pediatric age group. These neoplasms are often intramural and involve the left ventricular free wall or the interventricular septum. Although benign, FIBROMAs may become life-threatening by causing arrhythmias or obstruction to the blood flow. A case of supravalvular intraluminal ascending aorta FIBROMA in a 23-month-old girl, presenting with syncope, is described here; the location is rare and the presentation atypical for this type of tumor. Transesophageal echocardiography helped us to evaluate the anatomic details of the tumor and plan surgery.

Leiomyomata uteri are the most frequent myometrial disorders and the most common pelvic tumor in women. Although most women with uterine leiomyomas do not seek therapy, 20% to 40% of women in the reproductive age do have significant enough symptoms caused by these fibroids to cause the woman to seek and warrant therapy.Since 1995 uterine fibroid embolization (UFE) or uterine artery embolization (UAE) was originally devised to reduce pelvic bleeding due to postpartum hemorrhage. It has been introduced as a treatment for symptomatic uterine myomas sparing the uterus.Without a good blood supply, it has been shown fibroids will decrease in size between 30% and 50% and decrease in symptomatology.Initial studies have shown that UAE can improve menorrhagia in 90% of patients at 1 year after therapy. On average, the volume of the fibroids decrease by 30%–60% and the associated symptoms (of mass effect) are successfully treated in 71% of patients.Complications include postprocedure pain and postembolization syndrome possibly related to the release of cytokines and toxins from the ischemic tissue.Vascular anastomotic communications between the uterine and ovarian arteries provide a route by which embolization materials can affect the ovarian blood supply and ovarian function, either permanently or temporarily. So Currently, UAE is not recommended as the first line of therapy in patients with infertility presumed to be caused by fibroids.Magnetic resonance imaging–guided focused ultrasound surgery (MRIgFUS) is another groundbreaking minimally invasive alternative to surgery for fibroids. Focused ultrasound causes local tissue thermal coagulation, ablates the target fibroid, and allows preservation of uterine function. It is a feasible and safe outpatient procedure that does not require hospitalization.The procedure begins with the delivery of low-power (50–100 watt) sonication, with real-time thermometry acquired simultaneously. We will discuss these two techniques in detail and share our experience.

In 1991, Handlers and colleagues described the Central odontogenicFIBROMA (COF) as a distinct entity which is a rare benign odontogenic tumour and up to the present, only 78 cases of it have been published. COF usually occurs in an adult patient and has a predilection for the anterior region of the jaws. A 2.8: 1 female to mail ratio is typically noted. This article presents a case of COF in a 50-year-old male in the right side of mandible and discuss about the clinic pathologicalfind-.ings, radiographic feature, differential diagnosis, as well as surgical technique of the COF.

The patient was a 37-year-old woman with abdominal pain. A huge mass was noticed during the abdominal examination, and ultrasonography reported a large uterine FIBROMA with the size of 105x100x101 mm. The patient was hospitalized for abdominal hysterectomy. During the operation, opening the parietal peritoneum led to a massive bleeding and a drop in patient’s blood temperature. The FIBROMA was supplied by ileal mesentery vessels that were the main source of the bleeding. The ileal mesentery bleeding was controlled by silk suturing. We resected the FIBROMA but did not do a hysterectomy. Not only sonography but also CT and MRI are recommended to Such a problem.

Introduction: Central Odontogenic FIBROMA is an uncommon benign ectomesenchymal and somewhat controversial tumor of the jaw. This lesion is seen in all age groups and in both the mandible and maxilla.Case Report: In this report, a rare case of Central Odontogenic FIBROMA with the simple type predominance is presented in a 57-year-old man in the right maxillary canine edentulous region.The lesion was surgically removed. After enuleation and curettage, no recurrence was recorded during the next six months.Conclusion: Microscopically, because of histopathologic variability, two common variants have been described for COdF: Simple and WHO type. However, this microscopic differentiation may be academic because it appears to have no correlation with clinical behavior of the two variants.

Chondromyxoid FIBROMA is a rare benign neoplasm that rarely involves mandible. In this case a chondromixoid FIBROMA was reported in the posterior region of the left mandible. The relevant clinical, radiologic, and pathologic features and treatment of this case are presented. Surgery was performed under general anesthesia with extra oral access and resection of the lesion from the mesial of canine to distal of the third molar and AO plaques was used to maintain space and for secondary reconstruction.